Catalyst Event
Hansoh Pharmaceutical Group Company Limited (3692) · Other
From Akros SCHK HK-U.S. Tech 100 Index (ASHUSTC)
4/29/2026, 12:00:00 AM
Announced on 2026-04-29 that its B7-H3 targeted ADC, HS-20093, was granted Breakthrough Therapy Designation by China's NMPA for treating advanced castration-resistant prostate cancer. Medium importance is assigned as Breakthrough Therapy Designation is a significant milestone likely impacting price by >=5%.
Korean Translation
2026-04-29에 자체 개발 B7-H3 표적 ADC HS-20093이 진행성 거세 저항성 전립선암 치료용으로 중국 국가약품감독관리국(NMPA)으로부터 혁신치료제 지정을 받았음을 발표함. 혁신치료제 지정은 중요한 이정표로 5% 이상의 주가 영향이 예상되어 'Medium'으로 분류함.
Related Recent Events
WuXi Biologics (Cayman) Inc (2269) · Other
The U.S. Office of Management and Budget (OMB) is scheduled to publish a full list of 'biotechnology companies of concern' (BCCs) by December 18, 2026, under the BIOSECURE Act; High importance is justified by the potential for severe regulatory risk causing a >10% price impact scheduled.
12/18/2026, 12:00:00 AM
Honeywell International Inc (HON) · Trading Issue
Honeywell Aerospace spin-off is scheduled to be completed on June 29, 2026, marking the final step in the company's portfolio transformation. The new company will trade under the ticker 'HONA'. This event is scheduled.
6/29/2026, 12:00:00 AM
BYD Electronic International Co Ltd (285) · Other
Ex-dividend date (2026-06-11) for the final dividend of RMB 0.156 per share for the year ended December 31, 2025, scheduled. Low importance as dividend distributions typically result in price adjustments of ~1%.
6/11/2026, 12:00:00 AM
Honeywell International Inc (HON) · Other
A quarterly dividend of $1.19 per share is scheduled to be paid on June 5, 2026, to shareholders of record as of May 17, 2026. This event is scheduled.
6/5/2026, 12:00:00 AM
Time Interconnect Technology Ltd (1729) · Other
Annual General Meeting on 2026-05-29 to approve FY2025 results, a final dividend of HK2.4 cents per share, and a mandate to issue up to 20% new shares scheduled.
5/29/2026, 12:00:00 AM
SALESFORCE INC (CRM) · Earnings Release
Salesforce is scheduled to release its Q1 FY2027 earnings results on May 27, 2026, after market close. Importance is estimated as Low based on historical price stability during similar announcements, scheduled.
5/27/2026, 12:00:00 AM